DCN

decorin, the group of Small leucine rich repeat proteoglycans

Basic information

Region (hg38): 12:91140484-91183217

Links

ENSG00000011465NCBI:1634OMIM:125255HGNC:2705Uniprot:P07585AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • congenital stromal corneal dystrophy (Strong), mode of inheritance: AD
  • congenital stromal corneal dystrophy (Supportive), mode of inheritance: AD
  • congenital stromal corneal dystrophy (Definitive), mode of inheritance: AD
  • congenital stromal corneal dystrophy (Moderate), mode of inheritance: AD

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Corneal dystrophy, congenital stromalADOphthalmologicIn addition to other ophthalmologic care that may be effective (eg, penetrating keratoplasty), open-angle glaucoma has been described in several individuals, and awareness of this risk may allow surveillance and early treatmentOphthalmologic5304426; 15671264; 16935612; 20301741; 21993463; 24413633

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the DCN gene.

  • Inborn_genetic_diseases (48 variants)
  • Congenital_stromal_corneal_dystrophy (28 variants)
  • not_provided (14 variants)
  • DCN-related_disorder (3 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the DCN gene is commonly pathogenic or not. These statistics are base on transcript: NM_000001920.5. Only rare variants are included in the table.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
1
clinvar
5
clinvar
5
clinvar
11
missense
49
clinvar
5
clinvar
4
clinvar
58
nonsense
0
start loss
0
frameshift
4
clinvar
4
splice donor/acceptor (+/-2bp)
0
Total 4 0 50 10 9
Loading clinvar variants...

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
DCNprotein_codingprotein_codingENST00000052754 737876
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.3120.6871257340141257480.0000557
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.8011641960.8390.00001012357
Missense in Polyphen4160.9610.67256748
Synonymous-0.1497775.41.020.00000395708
Loss of Function2.93417.10.2340.00000105184

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.00006150.0000615
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.0002310.000231
European (Non-Finnish)0.00003520.0000352
Middle Eastern0.000.00
South Asian0.0001310.000131
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: May affect the rate of fibrils formation.;
Disease
DISEASE: Corneal dystrophy, congenital stromal (CSCD) [MIM:610048]: A corneal dystrophy characterized by congenital corneal opacification consisting of a large number of flakes and spots throughout all layers of the stroma. It results in progressive, painless visual loss. Corneal erosions and photophobia are absent. {ECO:0000269|PubMed:15671264}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
TGF-beta signaling pathway - Homo sapiens (human);Proteoglycans in cancer - Homo sapiens (human);Human Complement System;BMP2-WNT4-FOXO1 Pathway in Human Primary Endometrial Stromal Cell Differentiation;Metabolism of carbohydrates;A tetrasaccharide linker sequence is required for GAG synthesis;Heparan sulfate/heparin (HS-GAG) metabolism;Chondroitin sulfate biosynthesis;Dermatan sulfate biosynthesis;Chondroitin sulfate/dermatan sulfate metabolism;Glycosaminoglycan metabolism;Extracellular matrix organization;Metabolism;Integrin;Degradation of the extracellular matrix;ECM proteoglycans;Validated transcriptional targets of AP1 family members Fra1 and Fra2 (Consensus)

Recessive Scores

pRec
0.865

Intolerance Scores

loftool
0.728
rvis_EVS
-0.05
rvis_percentile_EVS
50.01

Haploinsufficiency Scores

pHI
0.607
hipred
Y
hipred_score
0.853
ghis
0.567

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.839

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Dcn
Phenotype
respiratory system phenotype; neoplasm; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); normal phenotype; hematopoietic system phenotype; digestive/alimentary phenotype; renal/urinary system phenotype; skeleton phenotype; cellular phenotype; immune system phenotype; endocrine/exocrine gland phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); growth/size/body region phenotype; craniofacial phenotype; muscle phenotype;

Zebrafish Information Network

Gene name
dcn
Affected structure
ceratobranchial cartilage
Phenotype tag
abnormal
Phenotype quality
decreased amount

Gene ontology

Biological process
kidney development;placenta development;skeletal muscle tissue development;aging;response to mechanical stimulus;animal organ morphogenesis;positive regulation of autophagy;negative regulation of endothelial cell migration;positive regulation of phosphatidylinositol 3-kinase signaling;positive regulation of macroautophagy;negative regulation of angiogenesis;peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan;extracellular matrix organization;chondroitin sulfate biosynthetic process;chondroitin sulfate catabolic process;dermatan sulfate biosynthetic process;response to lipopolysaccharide;wound healing;positive regulation of transcription by RNA polymerase II;positive regulation of mitochondrial depolarization;positive regulation of mitochondrial fission;negative regulation of vascular endothelial growth factor signaling pathway
Cellular component
extracellular region;collagen type VI trimer;extracellular space;Golgi lumen;lysosomal lumen;collagen-containing extracellular matrix
Molecular function
RNA binding;protein binding;collagen binding;glycosaminoglycan binding;extracellular matrix structural constituent conferring compression resistance;protein N-terminus binding;extracellular matrix binding